Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 20.31% is 32% above its 5-year average of 15.44%, near the high end of its 5-year range (11.15%–20.46%).
As of the fiscal period ended Tuesday, June 30, 2026. 3.70% above its 12-month average of 19.58%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 20.31%.
RETURN ON EQUITY (ROE)
20.31%
RETURN ON EQUITY (ROE) AVG TTM
19.58%
RETURN ON EQUITY (ROE) AVG 3Y
16.14%
RETURN ON EQUITY (ROE) AVG 5Y
15.44%
RETURN ON EQUITY (ROE) AVG 10Y
15.00%
RETURN ON EQUITY (ROE) AVG 15Y
15.32%
RETURN ON EQUITY (ROE) AVG 20Y
14.91%
CURRENT VS TTM AVG
+3.70%
CURRENT VS 3Y AVG
+25.80%
CURRENT VS 5Y AVG
+31.50%
CURRENT VS 10Y AVG
+35.37%
CURRENT VS 15Y AVG
+32.54%
CURRENT VS 20Y AVG
+36.24%
SECTOR MEDIAN · HEALTHCARE
13.01%
median of 84 covered companies
CURRENT VS SECTOR MEDIAN
+56.11%
vs the sector median at left
Universal Health Services, Inc.
Market Cap
$10.83B
Return on Equity (ROE)
20.31%
TTM Avg
19.58%
3Y Avg
16.14%
5Y Avg
15.44%
Market Cap
$10.80B
Return on Equity (ROE)
6.85%
TTM Avg
4.70%
3Y Avg
4.67%
5Y Avg
11.22%
Market Cap
$10.51B
Return on Equity (ROE)
9.77%
TTM Avg
10.54%
3Y Avg
10.84%
5Y Avg
19.93%
Market Cap
$11.37B
Return on Equity (ROE)
8.63%
TTM Avg
6.23%
3Y Avg
8.78%
5Y Avg
10.01%
Market Cap
$10.26B
Return on Equity (ROE)
3.10%
TTM Avg
-8.94%
3Y Avg
-15.72%
5Y Avg
1.14%
Market Cap
$10.21B
Return on Equity (ROE)
15.51%
TTM Avg
15.81%
3Y Avg
15.92%
5Y Avg
17.27%
Market Cap
$11.46B
Return on Equity (ROE)
N/A
TTM Avg
329.18%
3Y Avg
200.63%
5Y Avg
164.66%
Market Cap
$10.05B
Return on Equity (ROE)
11.23%
TTM Avg
7.12%
3Y Avg
6.90%
5Y Avg
7.16%
Market Cap
$9.96B
Return on Equity (ROE)
-0.17%
TTM Avg
18.91%
3Y Avg
22.60%
5Y Avg
24.60%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Universal Health Services, Inc. (UHS) | $10.83B | 20.31% | 19.58% | 16.14% | 15.44% |
| The Cooper Companies, Inc. (COO)vs › | $10.80B | 6.85% | 4.70% | 4.67% | 11.22% |
| Align Technology, Inc. (ALGN)vs › | $10.51B | 9.77% | 10.54% | 10.84% | 19.93% |
| Bio-Techne Corporation (TECH)vs › | $11.37B | 8.63% | 6.23% | 8.78% | 10.01% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $10.26B | 3.10% | -8.94% | -15.72% | 1.14% |
| The Ensign Group, Inc. (ENSG)vs › | $10.21B | 15.51% | 15.81% | 15.92% | 17.27% |
| DaVita Inc. (DVA)vs › | $11.46B | N/A | 329.18% | 200.63% | 164.66% |
| Globus Medical, Inc. (GMED)vs › | $10.05B | 11.23% | 7.12% | 6.90% | 7.16% |
| Molina Healthcare, Inc. (MOH)vs › | $9.96B | -0.17% | 18.91% | 22.60% | 24.60% |
| Henry Schein, Inc. (HSIC)vs › | $9.84B | 12.77% | 11.88% | 12.69% | 13.50% |
ROE
20.3%
ROA
9.6%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 20.31% |
| 2026-03-31 | 20.19% |
| 2025-12-31 | 20.46% |
| 2025-09-30 | 19.02% |
| 2025-06-30 | 17.94% |
| 2025-03-31 | 17.64% |
| 2024-12-31 | 17.13% |
| 2024-09-30 | 15.53% |
| 2024-06-30 | 14.41% |
| 2024-03-31 | 13.05% |
| 2023-12-31 | 11.67% |
| 2023-09-30 | 11.15% |
| 2023-06-30 | 11.37% |
| 2023-03-31 | 11.38% |
| 2022-12-31 | 11.40% |
| 2022-09-30 | 12.62% |
| 2022-06-30 | 13.31% |
| 2022-03-31 | 15.93% |
| 2021-12-31 | 16.25% |
| 2021-09-30 | 16.87% |
| 2021-06-30 | 16.68% |
| 2021-03-31 | 15.47% |
| 2020-12-31 | 14.90% |
| 2020-09-30 | 14.72% |
| 2020-06-30 | 12.91% |
| 2020-03-31 | 13.32% |
| 2019-12-31 | 14.77% |
| 2019-09-30 | 13.47% |
| 2019-06-30 | 14.84% |
| 2019-03-31 | 14.38% |
| 2018-12-31 | 14.45% |
| 2018-09-30 | 15.67% |
| 2018-06-30 | 15.23% |
| 2018-03-31 | 14.76% |
| 2017-12-31 | 15.07% |
| 2017-09-30 | 14.52% |
| 2017-06-30 | 14.90% |
| 2017-03-31 | 15.15% |
| 2016-12-31 | 15.49% |
| 2016-09-30 | 15.97% |
| 2016-06-30 | 16.27% |
| 2016-03-31 | 16.24% |
| 2015-12-31 | 16.01% |
| 2015-09-30 | 16.44% |
| 2015-06-30 | 15.06% |
| 2015-03-31 | 14.88% |
| 2014-12-31 | 14.59% |
| 2014-09-30 | 13.79% |
| 2014-06-30 | 14.91% |
| 2014-03-31 | 15.59% |
| 2013-12-31 | 15.71% |
| 2013-09-30 | 16.76% |
| 2013-06-30 | 16.00% |
| 2013-03-31 | 15.32% |
| 2012-12-31 | 16.32% |
| 2012-09-30 | 15.44% |
| 2012-06-30 | 16.40% |
| 2012-03-31 | 16.98% |
| 2011-12-31 | 17.32% |
| 2011-09-30 | 15.29% |
| 2011-06-30 | 14.20% |
| 2011-03-31 | 13.01% |
| 2010-12-31 | 11.63% |
| 2010-09-30 | 13.06% |
| 2010-06-30 | 13.21% |
| 2010-03-31 | 14.53% |
| 2009-12-31 | 14.87% |
| 2009-09-30 | 14.23% |
| 2009-06-30 | 13.82% |
| 2009-03-31 | 13.63% |
| 2008-12-31 | 13.72% |
| 2008-09-30 | 13.10% |
| 2008-06-30 | 12.76% |
| 2008-03-31 | 12.27% |
| 2007-12-31 | 11.23% |
| 2007-09-30 | 10.72% |
| 2007-06-30 | 16.48% |
| 2007-03-31 | 17.65% |
| 2006-12-31 | 18.50% |
| 2006-09-30 | 15.88% |
| 2006-06-30 | 8.62% |
| 2006-03-31 | 18.37% |
| 2005-12-31 | 19.99% |
| 2005-09-30 | 21.71% |
| 2005-06-30 | 23.04% |
| 2005-03-31 | 14.49% |
| 2004-12-31 | 13.89% |
| 2004-09-30 | 14.72% |
| 2004-06-30 | 16.12% |
| 2004-03-31 | 17.00% |
| 2003-12-31 | 18.27% |
| 2003-09-30 | 19.20% |
| 2003-06-30 | 19.36% |